November 6, 2014 / 7:21 AM / 5 years ago

BRIEF-Astrazeneca sells Myalept to Aegerion

Nov 6 (Reuters) - Astrazeneca Plc

* To divest myalept to aegerion

* Entered into a definitive agreement with aegerion pharmaceuticals, inc. To divest myalept (metreleptin for injection), Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below